{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T12:19:40Z","timestamp":1790943580727,"version":"4.1.0"},"reference-count":138,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1016\/j.vaccine.2009.08.059","type":"journal-article","created":{"date-parts":[[2009,10,17]],"date-time":"2009-10-17T08:27:11Z","timestamp":1255768031000},"page":"D33-D39","source":"Crossref","is-referenced-by-count":105,"special_numbering":"S4","title":["Botulism and vaccines for its prevention"],"prefix":"10.1016","volume":"27","author":[{"given":"Leonard A.","family":"Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2009.08.059_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF02220526","article-title":"Ueber einen neuer anaeroben bacillus und seine beziehunger zum botulismus","volume":"26","author":"Van Ermengem","year":"1897","journal-title":"Zeit f Hyg"},{"key":"10.1016\/j.vaccine.2009.08.059_bib2","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/BF02284114","article-title":"Beitrage sur kentniss die toxin und antitoxin des bacillus botulinus","volume":"65","author":"Leuchs","year":"1910","journal-title":"Zeit Hyg Infektionskrankh"},{"key":"10.1016\/j.vaccine.2009.08.059_bib3","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1126\/science.130.3378.763","article-title":"The most poisonous poison","volume":"130","author":"Lamanna","year":"1959","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2009.08.059_bib4","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1128\/JCM.21.4.654-655.1985","article-title":"Isolation of an organism resembling Clostridium barati which produces type F botulinal toxin from an infant with botulism","volume":"4","author":"Hall","year":"1985","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2009.08.059_bib5","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1128\/JCM.23.1.201-202.1986","article-title":"Characterization of an organism that produces type E botulinal toxin but which resembles Clostridium butyricum from the feces of an infant with type E botulism","volume":"1","author":"McCroskey","year":"1986","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2009.08.059_bib6","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/infdis\/154.2.207","article-title":"Two cases of type E infant botulism caused by neurotoxigenic Clostridium butyricum in Italy","volume":"154","author":"Aureli","year":"1986","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2009.08.059_bib7","first-page":"221","article-title":"Another type of Clostridium botulinum","volume":"215","author":"Gim\u00e9nez","year":"1970","journal-title":"Zentralbl Bakteriol Orig"},{"key":"10.1016\/j.vaccine.2009.08.059_bib8","series-title":"Botulism proceedings of a symposium","first-page":"165","article-title":"Preparation, evaluation, and use of C. botulinum antitoxins","author":"Harrell","year":"1964"},{"key":"10.1016\/j.vaccine.2009.08.059_bib9","series-title":"Clostridium botulinum\u2014ecology and control in foods","first-page":"3","article-title":"Clostridium botulinum and other clostridia that produce botulinum neurotoxins","author":"Hatheway","year":"1992"},{"key":"10.1016\/j.vaccine.2009.08.059_bib10","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1128\/MMBR.44.3.419-448.1980","article-title":"Clostridium botulinum neurotoxin","volume":"44","author":"Sugiyama","year":"1980","journal-title":"Microbiol Rev"},{"key":"10.1016\/j.vaccine.2009.08.059_bib11","series-title":"Handbook for epidemiologists, clinicians and laboratory workers","author":"Centers for Disease Control and Prevention. Botulism in the United States, 1899\u20131998","year":"1998"},{"key":"10.1016\/j.vaccine.2009.08.059_bib12","first-page":"643","article-title":"Botulinum toxins","volume":"33","author":"Middlebrook","year":"1997"},{"key":"10.1016\/j.vaccine.2009.08.059_bib13","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1093\/infdis\/46.4.335","article-title":"Susceptibility of monkeys, goats and small animals to oral administration of botulinum toxin types B, C and D","volume":"46","author":"Gunnison","year":"1930","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2009.08.059_bib14","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/infdis\/109.2.107","article-title":"Clostridium botulinum type F with recent observations on other types","volume":"109","author":"Dolman","year":"1961","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2009.08.059_bib15","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1136\/vr.107.19.445","article-title":"An outbreak of type C botulism in captive monkeys","volume":"107","author":"Smart","year":"1980","journal-title":"Vet Rec"},{"key":"10.1016\/j.vaccine.2009.08.059_bib16","first-page":"441","article-title":"Botulinum neurotoxin serotypes C and E: clinical trials","volume":"42","author":"Eleopra","year":"2002"},{"key":"10.1016\/j.vaccine.2009.08.059_bib17","first-page":"1019","article-title":"Bacterial protein toxins as biological weapons","volume":"vol. 62","author":"Smith","year":"2006"},{"key":"10.1016\/j.vaccine.2009.08.059_bib18","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1152\/physrev.2000.80.2.717","article-title":"Neurotoxins affecting neuroexocytosis","volume":"80","author":"Schiavo","year":"2000","journal-title":"Physiol Rev"},{"key":"10.1016\/j.vaccine.2009.08.059_bib19","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1146\/annurev.pharmtox.44.101802.121554","article-title":"Identification of the major steps in botulinum toxin action","volume":"44","author":"Simpson","year":"2004","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.vaccine.2009.08.059_bib20","first-page":"1","article-title":"Botulinum toxin","volume":"1","author":"Dembek","year":"2007","journal-title":"J Dis Med Pub Health Prep"},{"key":"10.1016\/j.vaccine.2009.08.059_bib21","first-page":"91","article-title":"Insights into the extended duration of neuroparalysis by botulinum neurotoxin A relative to the other shorter-acting serotypes: differences between motor nerve terminals and cultured neurons","volume":"vol. 8","author":"Dolly","year":"2002"},{"key":"10.1016\/j.vaccine.2009.08.059_bib22","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1074\/jbc.M209821200","article-title":"Evaluation of the therapeutic usefulness of botulinum neurotoxin B, C1, E, and F compared to the long-lasting type A: basis for distinct durations of inhibition of exocytosis in central neurons","volume":"278","author":"Foran","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2009.08.059_bib23","first-page":"299","article-title":"Die werthbemessung des diphtheria heil-serum und deren theoretische grundlagen","volume":"6","author":"Erlich","year":"1897","journal-title":"Klin Jahrb Jena"},{"key":"10.1016\/j.vaccine.2009.08.059_bib24","first-page":"2","article-title":"Pouvior floculant et pouvoir toxique de la toxine diphterique","volume":"89","author":"Ramon","year":"1923","journal-title":"Compt Rend de la Soc de Biol Paris"},{"key":"10.1016\/j.vaccine.2009.08.059_bib25","first-page":"1338","article-title":"Sur le pouvoir floculant et sur les proprietes immunisantes d\u2019une toxine diphterique rendue anatoxique (anatoxine)","volume":"177","author":"Ramon","year":"1923","journal-title":"C R Acad Sci Paris"},{"key":"10.1016\/j.vaccine.2009.08.059_bib26","first-page":"1","article-title":"Sur la toxine et sur l\u2019anatoxine dipht\u00e9riques: pouvoir floculant et proprieties immunisantes","volume":"38","author":"Ramon","year":"1924","journal-title":"Ann Inst Pasteur"},{"key":"10.1016\/j.vaccine.2009.08.059_bib27","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1055\/s-0029-1204301","article-title":"Ueber Tetanusgift und Tetanusantitoxin","volume":"24","author":"von Behring","year":"1898","journal-title":"Deutsch Med Woch"},{"key":"10.1016\/j.vaccine.2009.08.059_bib28","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/BF02217451","article-title":"Ueber active Schutzimpfung bei Tetanus durch Toxoide","volume":"62","author":"Lowenstein","year":"1909","journal-title":"Ztschr f Hyg u Infektionskrankh"},{"key":"10.1016\/j.vaccine.2009.08.059_bib29","first-page":"271","article-title":"Ueber Formalinwirkung auf Tetanustoxin und andere Bakterien-toxine","volume":"61","author":"von Eisler","year":"1911","journal-title":"Zentr f Bakt 1 Abt Orig"},{"key":"10.1016\/j.vaccine.2009.08.059_bib30","first-page":"269","article-title":"Recherches sur la toxine botulinque","volume":"90","author":"Weinberg","year":"1924","journal-title":"Compt Rend Soc Biol"},{"key":"10.1016\/j.vaccine.2009.08.059_bib31","first-page":"21","article-title":"The antigenic value of formalized botulinum toxins","volume":"75","author":"Graham","year":"1929","journal-title":"J Am Met Vet Assoc"},{"key":"10.1016\/j.vaccine.2009.08.059_bib32","doi-asserted-by":"crossref","first-page":"305","DOI":"10.4049\/jimmunol.20.4.305","article-title":"Antigenic value of botulinum toxoids kept one year at ice box temperature","volume":"20","author":"Graham","year":"1931","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2009.08.059_bib33","first-page":"186","article-title":"Experimental vaccination against botulism","volume":"70","author":"Velikanov","year":"1931","journal-title":"Z Immunitatsforsch"},{"key":"10.1016\/j.vaccine.2009.08.059_bib34","first-page":"641","article-title":"Etudes sur la toxine et l\u2019antitoxine botuliques","volume":"120","author":"Legroux","year":"1935","journal-title":"Compt Rend Soc Biol"},{"key":"10.1016\/j.vaccine.2009.08.059_bib35","first-page":"262","article-title":"Toxine et anatoxine botulique","volume":"123","author":"Jakobkiewicz","year":"1936","journal-title":"Compt Rend Soc Biol"},{"key":"10.1016\/j.vaccine.2009.08.059_bib36","first-page":"209","article-title":"Toxine et anatoxine botulique","volume":"2","author":"Jeramec","year":"1936","journal-title":"Rev Immunol"},{"key":"10.1016\/j.vaccine.2009.08.059_bib37","first-page":"33","article-title":"Active immunization against botulism","volume":"4","author":"Melnik","year":"1936","journal-title":"Ann Inst Metch"},{"key":"10.1016\/j.vaccine.2009.08.059_bib38","first-page":"1802","article-title":"Experimental immunization of man against botulism","volume":"12","author":"Velikanov","year":"1934","journal-title":"Klin Med"},{"key":"10.1016\/j.vaccine.2009.08.059_bib39","first-page":"451","article-title":"Immunization experimentale de l\u2019homme contra la botulisme","volume":"17","author":"Velikanov","year":"1936","journal-title":"Giorn Batteriol E Immunol"},{"key":"10.1016\/j.vaccine.2009.08.059_bib40","doi-asserted-by":"crossref","first-page":"245","DOI":"10.4049\/jimmunol.55.3.245","article-title":"Studies on botulinum toxoid, types A and B. I. Production of alum-precipitated toxoids","volume":"55","author":"Nigg","year":"1947","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2009.08.059_bib41","doi-asserted-by":"crossref","first-page":"255","DOI":"10.4049\/jimmunol.55.3.255","article-title":"Studies on botulinum toxoids, types A and B. II. Methods for determining antigenicity in animals","volume":"55","author":"Hottle","year":"1947","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2009.08.059_bib42","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1139\/cjr47e-016","article-title":"Clostridium botulinum type A toxoids","volume":"25","author":"Rice","year":"1947","journal-title":"Can J Res"},{"key":"10.1016\/j.vaccine.2009.08.059_bib43","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1139\/cjr47e-017","article-title":"Clostridium botulinum type B toxoids","volume":"25","author":"Rice","year":"1947","journal-title":"Can J Res"},{"key":"10.1016\/j.vaccine.2009.08.059_bib44","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1139\/cjr47e-018","article-title":"Preliminary study of antigenic activity of mixtures of Clostridium botulinum toxoid types A and B","volume":"25","author":"Rice","year":"1947","journal-title":"Can J Res"},{"key":"10.1016\/j.vaccine.2009.08.059_bib45","doi-asserted-by":"crossref","first-page":"309","DOI":"10.4049\/jimmunol.55.4.309","article-title":"Studies on botulinum toxoid, types A and B. III. Immunization of man","volume":"55","author":"Reames","year":"1947","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2009.08.059_bib46","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1128\/JB.73.1.42-47.1957","article-title":"Studies on immunity to toxins of Clostridium botulinum. I. A simplified procedure for isolation of type A toxin","volume":"73","author":"Duff","year":"1957","journal-title":"J Bacteriol"},{"key":"10.1016\/j.vaccine.2009.08.059_bib47","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1128\/JB.73.5.597-601.1957","article-title":"Studies on immunity to toxins of Clostridium botulinum. II. A simplified procedure for isolation of type A toxin","volume":"73","author":"Duff","year":"1957","journal-title":"J Bacteriol"},{"key":"10.1016\/j.vaccine.2009.08.059_bib48","doi-asserted-by":"crossref","first-page":"384","DOI":"10.4049\/jimmunol.84.4.384","article-title":"Studies on immunity to toxins of Clostridium botulinum. V. Detoxification of purified type A and B toxins, and the antigenicity of univalent and bivalent aluminum phosphate adsorbed toxoids","volume":"84","author":"Wright","year":"1960","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2009.08.059_bib49","doi-asserted-by":"crossref","first-page":"277","DOI":"10.4049\/jimmunol.88.3.277","article-title":"Studies on immunity to toxins of Clostridium botulinum. VIII. Immunological response of man to purified bivalent AB botulinum toxoid","volume":"88","author":"Fiock","year":"1962","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2009.08.059_bib50","series-title":"Botulism. Proc. of symposium","first-page":"113","article-title":"Botulinal toxoid","author":"Cardella","year":"1964"},{"key":"10.1016\/j.vaccine.2009.08.059_bib51","series-title":"Developments in diphtheria prophylaxis","author":"Holt","year":"1950"},{"key":"10.1016\/j.vaccine.2009.08.059_bib52","series-title":"Botulism: the organism, its toxin, the disease","first-page":"152","article-title":"Botulinum toxoids","author":"Smith","year":"1977"},{"key":"10.1016\/j.vaccine.2009.08.059_bib53","doi-asserted-by":"crossref","first-page":"667","DOI":"10.4049\/jimmunol.90.5.697","article-title":"Studies on immunity to toxins of Clostridium botulinum. IX. Immunologic response of man to purified ABCDE botulinum toxoid","volume":"90","author":"Fiock","year":"1963","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2009.08.059_bib54","series-title":"Immunobiologic agents and drugs available from the Centers for Disease Control: description, recommendations, adverse events, and serologic response","author":"Ellis","year":"1982"},{"key":"10.1016\/j.vaccine.2009.08.059_bib55","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1615\/CritRevImmunol.v27.i4.20","article-title":"Botulinum neurotoxin vaccines: past, the present, and future","volume":"27","author":"Smith","year":"2007","journal-title":"Crit Rev Immunol"},{"key":"10.1016\/j.vaccine.2009.08.059_bib56","doi-asserted-by":"crossref","unstructured":"Rusnak JM, Smith LA. Botulinum neurotoxin vaccines: past history and recent developments. Hum Vaccin in press; December 2009:5, Issue.","DOI":"10.4161\/hv.9420"},{"key":"10.1016\/j.vaccine.2009.08.059_bib57","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1016\/S0264-410X(02)00157-3","article-title":"Production and immunogenic efficacy of botulinum tetravalent (A, B, E, F) toxoid","volume":"20","author":"Torii","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.08.059_bib58","series-title":"43rd Interagency Botulism Research Coordinating Committee meeting","article-title":"Bivalent AB botulinum toxoid (BBT)","author":"Tong","year":"2006"},{"key":"10.1016\/j.vaccine.2009.08.059_bib59","series-title":"Meeting of the Interagency Botulism Research Coordinating Committee","article-title":"Immunogenicity and animal efficacy studies of botulinum toxoid vaccines","author":"Agostini","year":"2008"},{"key":"10.1016\/j.vaccine.2009.08.059_bib60","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jim.2008.05.009","article-title":"An improved method for development of toxoid vaccines and antitoxins","volume":"337","author":"Jones","year":"2008","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.vaccine.2009.08.059_bib61","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1128\/CVI.00117-08","article-title":"Characterization of new formalin-detoxified botulinum neurotoxin toxoids","volume":"15","author":"Keller","year":"2008","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2009.08.059_bib62","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/0006-291X(74)90832-8","article-title":"Enzymatic breakdown of tetanus toxin","volume":"57","author":"Helting","year":"1974","journal-title":"Biochim Biophys Res Commun"},{"key":"10.1016\/j.vaccine.2009.08.059_bib63","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0021-9258(17)32814-4","article-title":"Structure of tetanus toxin. I. Breakdown of the toxin molecule and discrimination between polypeptide fragments","volume":"252","author":"Helting","year":"1977","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2009.08.059_bib64","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0021-9258(17)38278-9","article-title":"Toxicity of papain-digested tetanus toxin. Pathological effect of fragment B in the absence of spastic paralysis","volume":"253","author":"Helting","year":"1978","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2009.08.059_bib65","first-page":"59","article-title":"Analysis of the immune response to papain digestion products of tetanus toxin","volume":"92","author":"Helting","year":"1984","journal-title":"Acta Pathol Microbiol Scand C"},{"key":"10.1016\/j.vaccine.2009.08.059_bib66","doi-asserted-by":"crossref","first-page":"7809","DOI":"10.1093\/nar\/14.19.7809","article-title":"The complete nucleotide sequence of tetanus toxin","volume":"14","author":"Fairweather","year":"1986","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.vaccine.2009.08.059_bib67","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1128\/jb.165.1.21-27.1986","article-title":"Cloning, nucleotide sequencing, and expression of tetanus toxin fragment C in Escherichia coli","volume":"165","author":"Fairweather","year":"1986","journal-title":"J Bacteriol"},{"key":"10.1016\/j.vaccine.2009.08.059_bib68","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1002\/j.1460-2075.1986.tb04527.x","article-title":"Tetanus toxin: primary structure, expression in E. coli, and homology with botulinum toxins","volume":"5","author":"Eisell","year":"1986","journal-title":"EMBO J"},{"key":"10.1016\/j.vaccine.2009.08.059_bib69","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1128\/IAI.55.11.2541-2545.1987","article-title":"Immunization of mice against tetanus with fragments of tetanus toxin synthesized in Escherichia coli","volume":"55","author":"Fairweather","year":"1987","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2009.08.059_bib70","first-page":"1043","article-title":"Expression of tetanus toxin fragment C in E. coli: its purification and potential use as a vaccine","volume":"7","author":"Makoff","year":"1989","journal-title":"Biotechnology"},{"key":"10.1016\/j.vaccine.2009.08.059_bib71","doi-asserted-by":"crossref","first-page":"10191","DOI":"10.1093\/nar\/17.24.10191","article-title":"Expression of tetanus toxin fragment C in E. coli: high level expression by removing rare codons","volume":"17","author":"Makoff","year":"1989","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.vaccine.2009.08.059_bib72","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1093\/nar\/19.7.1461","article-title":"Expression of tetanus toxin fragment C in yeast: gene synthesis is required to eliminate fortuitous polyadenylation sites in AT-rich DNA","volume":"19","author":"Romanos","year":"1991","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.vaccine.2009.08.059_bib73","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/yea.320080602","article-title":"Foreign gene expression in yeast: a review","volume":"8","author":"Romanos","year":"1992","journal-title":"Yeast"},{"key":"10.1016\/j.vaccine.2009.08.059_bib74","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/nbt0591-455","article-title":"High-level expression of tetanus toxin fragment C in Pichia pastoris strains containing multiple tandem integrations of the gene","volume":"9","author":"Clare","year":"1991","journal-title":"Biotechnology"},{"key":"10.1016\/j.vaccine.2009.08.059_bib75","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1432-1033.1990.tb15461.x","article-title":"The complete amino acid sequence of the Clostridium botulinum type A neurotoxin, deduced by nucleotide sequence analysis of the encoding gene","volume":"189","author":"Thompson","year":"1990","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.vaccine.2009.08.059_bib76","doi-asserted-by":"crossref","first-page":"5556","DOI":"10.1093\/nar\/18.18.5556","article-title":"Nucleotide sequence of the gene encoding Clostridium botulinum neurotoxin type D","volume":"18","author":"Binz","year":"1990","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.vaccine.2009.08.059_bib77","doi-asserted-by":"crossref","first-page":"4924","DOI":"10.1093\/nar\/18.16.4924","article-title":"Nucleotide sequence of Clostridium botulinum C1 neurotoxin","volume":"18","author":"Hauser","year":"1990","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.vaccine.2009.08.059_bib78","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/0006-291X(90)90828-B","article-title":"The complete nucleotide sequence of the gene coding for botulinum type C1 toxin in the C-ST phage genome","volume":"171","author":"Kimura","year":"1990","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.vaccine.2009.08.059_bib79","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1128\/AEM.58.8.2345-2354.1992","article-title":"Molecular cloning of the Clostridium botulinum structural gene encoding the type B neurotoxin and determination of its entire nucleotide sequence","volume":"58","author":"Whelan","year":"1992","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.vaccine.2009.08.059_bib80","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/j.1432-1033.1992.tb16679.x","article-title":"The complete amino acid sequence of the Clostridium botulinum type-E neurotoxin derived by nucleotide-sequence analysis of the encoding gene","volume":"204","author":"Whelan","year":"1992","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.vaccine.2009.08.059_bib81","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1574-6968.1992.tb05421.x","article-title":"Sequence of the gene encoding type F neurotoxin of Clostridium botulinum","volume":"96","author":"East","year":"1992","journal-title":"FEMS Microbiol Lett"},{"key":"10.1016\/j.vaccine.2009.08.059_bib82","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/0006-291X(92)91615-W","article-title":"Sequences of the botulinal neurotoxin E derived from Clostridium botulinum type E (strain Beluga) and Clostridium butyricum (strains ATCC 43181 and ATCC 43755)","volume":"183","author":"Poulet","year":"1992","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.vaccine.2009.08.059_bib83","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/0167-4781(93)90020-E","article-title":"Nucleotide sequence of the gene coding for Clostridium botulinum (Clostridium argentinense) type G neurotoxin: genealogical comparison with other clostridial neurotoxins","volume":"1216","author":"Campbell","year":"1993","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.vaccine.2009.08.059_bib84","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0723-2020(11)80444-3","article-title":"Nucleotide sequence of the gene coding for proteolytic (group I) Clostridium botulinum type F neurotoxin: genealogical comparison with other clostridial neurotoxins","volume":"18","author":"Elmore","year":"1995","journal-title":"Syst Appl Microbiol"},{"key":"10.1016\/j.vaccine.2009.08.059_bib85","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1574-6968.1993.tb06095.x","article-title":"Nucleotide sequence of the gene coding for Clostridium barati type F neurotoxin: comparison with other clostridial neurotoxins","volume":"108","author":"Thompson","year":"1993","journal-title":"FEMS Microbiol Lett"},{"key":"10.1016\/j.vaccine.2009.08.059_bib86","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/0923-2508(93)90004-L","article-title":"Sequence of the gene coding for the neurotoxin of Clostridium botulinum type A associated with infant botulism: comparison with other clostridial neurotoxins (1993)","volume":"144","author":"Willems","year":"1993","journal-title":"Res Microbiol"},{"key":"10.1016\/j.vaccine.2009.08.059_bib87","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/BF01569055","article-title":"Nucleotide sequence of the gene coding for non-proteolytic Clostridium botulinum type B neurotoxin: comparison with other clostridial neurotoxins","volume":"28","author":"Hutson","year":"1994","journal-title":"Curr Microbiol"},{"key":"10.1016\/j.vaccine.2009.08.059_bib88","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1038\/2338","article-title":"Crystal structure of botulinum neurotoxin type A and implications for toxicity","volume":"5","author":"Lacy","year":"1998","journal-title":"Nat Struct Biol"},{"key":"10.1016\/j.vaccine.2009.08.059_bib89","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/78005","article-title":"Structural analysis of the catalytic and binding sites of Clostridium botulinum neurotoxin B","volume":"7","author":"Swaminathan","year":"2000","journal-title":"Nat Struct Biol"},{"key":"10.1016\/j.vaccine.2009.08.059_bib90","doi-asserted-by":"crossref","first-page":"24777","DOI":"10.1074\/jbc.M703446200","article-title":"A novel subunit structure of Clostridium botulinum serotype D toxin complex with three extended arms","volume":"24","author":"Hasegawa","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2009.08.059_bib91","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jmb.2008.12.027","article-title":"Domain organization in Clostridium botulinum neurotoxin type E is unique: its implication in faster translocation","volume":"386","author":"Kumaran","year":"2009","journal-title":"J Mol Biol"},{"key":"10.1016\/j.vaccine.2009.08.059_bib92","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/nsmb.1626","article-title":"Mode of VAMP substrate recognition and inhibition of Clostridium botulinum neurotoxin type F","volume":"16","author":"Agarwal","year":"2009","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.vaccine.2009.08.059_bib93","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1128\/IAI.63.7.2738-2742.1995","article-title":"Protective vaccination with a recombinant fragment of Clostridium botulinum neurotoxin serotype A expressed from a synthetic gene in Escherichia coli","volume":"63","author":"Clayton","year":"1995","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2009.08.059_bib94","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1016\/S0041-0101(98)00146-9","article-title":"Development of recombinant vaccines for botulinum neurotoxin","volume":"36","author":"Smith","year":"1998","journal-title":"Toxicon"},{"key":"10.1016\/j.vaccine.2009.08.059_bib95","doi-asserted-by":"crossref","first-page":"6998","DOI":"10.1128\/IAI.73.10.6998-7005.2005","article-title":"Characterization of the antibody response to the receptor binding domain of botulinum neurotoxin serotypes A and E","volume":"73","author":"Baldwin","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2009.08.059_bib96","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1128\/IAI.01025-07","article-title":"Subunit vaccine against the seven serotypes of botulism","volume":"76","author":"Baldwin","year":"2008","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2009.08.059_bib97","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1016\/j.vaccine.2009.02.091","article-title":"The recombinant Hc subunit of Clostridium botulinum neurotoxin serotype A is an effective botulism vaccine candidate","volume":"27","author":"Yu","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.08.059_bib98","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0300-9084(00)01173-1","article-title":"Development of vaccines for prevention of botulism","volume":"82","author":"Byrne","year":"2000","journal-title":"Biochimie"},{"key":"10.1016\/j.vaccine.2009.08.059_bib99","doi-asserted-by":"crossref","first-page":"4817","DOI":"10.1128\/IAI.66.10.4817-4822.1998","article-title":"Purification, potency, and efficacy of the recombinant vaccine candidate botulinum neurotoxin type A binding domain from Pichia pastoris","volume":"66","author":"Byrne","year":"1998","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2009.08.059_bib100","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1006\/prep.2000.1256","article-title":"Production and purification of the heavy chain fragment C of botulinum neurotoxin, serotype A, expressed in the methylotrophic yeast Pichia pastoris","volume":"19","author":"Potter","year":"2000","journal-title":"Protein Expr Purif"},{"key":"10.1016\/j.vaccine.2009.08.059_bib101","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1021\/bp025516w","article-title":"Design of methanol feed control in Pichia pastoris fermentations based upon a growth model","volume":"6","author":"Zhang","year":"2002","journal-title":"Biotechnol Prog"},{"key":"10.1016\/j.vaccine.2009.08.059_bib102","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1002\/mds.20009","article-title":"Roads from vaccines to therapies","volume":"19","author":"Smith","year":"2004","journal-title":"Mov Disord"},{"key":"10.1016\/j.vaccine.2009.08.059_bib103","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1006\/prep.1998.0910","article-title":"Production and purification of the heavy chain fragment C of botulinum neurotoxin, serotype B, expressed in the methylotropic yeast Pichia pastoris","volume":"13","author":"Potter","year":"1998","journal-title":"Protein Expr Purif"},{"key":"10.1016\/j.vaccine.2009.08.059_bib104","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.toxicon.2006.02.013","article-title":"Recombinant C fragment of botulinum neurotoxin B serotype (rBoNTB (Hc)) immune response and protection in the rhesus monkey","volume":"47","author":"Boles","year":"2006","journal-title":"Toxicon"},{"key":"10.1016\/j.vaccine.2009.08.059_bib105","doi-asserted-by":"crossref","first-page":"4273","DOI":"10.1016\/j.vaccine.2007.02.081","article-title":"Protection with recombinant Clostridium botulinum C1 and D binding domain subunit (Hc) vaccines against C and D neurotoxins","volume":"25","author":"Webb","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.08.059_bib106","unstructured":"Loveless BM. Clostridium botulinum neurotoxin type E binding domain from Pichia pastoris as a recombinant vaccine candidate. Master of Science Thesis. Frederick, MD: Hood College; 2001."},{"key":"10.1016\/j.vaccine.2009.08.059_bib107","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.pep.2005.08.015","article-title":"Purification and scale-up of a recombinant heavy chain fragment C of botulinum neurotoxin serotype E in Pichia pastoris","volume":"45","author":"Dux","year":"2006","journal-title":"Protein Expr Purif"},{"key":"10.1016\/j.vaccine.2009.08.059_bib108","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1006\/prep.2000.1200","article-title":"Fermentation, purification, and efficacy of a recombinant vaccine candidate against botulinum neurotoxin serotype F from Pichia pastoris","volume":"18","author":"Byrne","year":"2000","journal-title":"Protein Expr Purif"},{"key":"10.1016\/j.vaccine.2009.08.059_bib109","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pep.2003.07.003","article-title":"Scale-up of the fermentation and purification of the recombinant heavy chain fragment C of botulinum neurotoxin serotype F, expressed in Pichia pastoris","volume":"32","author":"Johnson","year":"2003","journal-title":"Protein Expr Purif"},{"key":"10.1016\/j.vaccine.2009.08.059_bib110","first-page":"1","article-title":"Protection from multiple bacterial and toxin-mediated diseases using an intradermal vaccine array","volume":"6","author":"Morefield","year":"2008","journal-title":"J Immune Based Ther Vacc"},{"key":"10.1016\/j.vaccine.2009.08.059_bib111","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1016\/S0264-410X(99)00253-4","article-title":"Vaccination of mice with DNA encoding a large fragment of botulinum neurotoxin serotype A","volume":"18","author":"Clayton","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.08.059_bib112","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/BF02255918","article-title":"DNA vaccination using the fragment C of botulinum neurotoxin type A provided protective immunity in mice","volume":"7","author":"Shyu","year":"2000","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.vaccine.2009.08.059_bib113","doi-asserted-by":"crossref","first-page":"3110","DOI":"10.1016\/S0264-410X(03)00260-3","article-title":"DNA vaccination protects against botulinum neurotoxin type F","volume":"21","author":"Bennett","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.08.059_bib114","doi-asserted-by":"crossref","first-page":"3942","DOI":"10.1016\/j.vaccine.2004.04.006","article-title":"Efficacy of DNA vaccines expressing the type F botulinum toxin Hc fragment using different promoters","volume":"22","author":"Jathoul","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.08.059_bib115","doi-asserted-by":"crossref","first-page":"5709","DOI":"10.1128\/IAI.69.9.5709-5715.2001","article-title":"Candidate vaccine against botulinum neurotoxin serotype A derived from a Venezuelan equine encephalitis virus vector system","volume":"69","author":"Lee","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2009.08.059_bib116","doi-asserted-by":"crossref","first-page":"6886","DOI":"10.1016\/j.vaccine.2006.06.004","article-title":"Multiagent vaccines vectored by Venezuelan equine encephalitis virus replicon elicits immune responses to Marburg virus and protection against anthrax and botulinum neurotoxin in mice","volume":"24","author":"Lee","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.08.059_bib117","doi-asserted-by":"crossref","first-page":"8843","DOI":"10.1016\/j.vaccine.2007.10.016","article-title":"Enhanced immune responses using plasmid DNA replicon encoding the Hc domain of Clostridium botulinum neurotoxin serotype A","volume":"25","author":"Yu","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.08.059_bib118","doi-asserted-by":"crossref","first-page":"7540","DOI":"10.1016\/j.vaccine.2007.08.035","article-title":"Protective immunity against botulism provided by a single dose vaccination with an adenovirus-vectored vaccine","volume":"27","author":"Zeng","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.08.059_bib119","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/gt.2008.181","article-title":"An adenoviral vector-based mucosal is effective in protection against botulism","volume":"16","author":"Xu","year":"2009","journal-title":"Gene Ther"},{"key":"10.1016\/j.vaccine.2009.08.059_bib120","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/S0264-410X(02)00622-9","article-title":"Vaccination against type F botulinum toxin using attenuated Salmonella enterica var Typhimurium strains expressing the BoNT\/F Hc fragment","volume":"21","author":"Foynes","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.08.059_bib121","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1128\/IAI.71.3.1147-1154.2003","article-title":"Inhalational poisoning by botulinum toxin and inhalation vaccination with its heavy-chain component","volume":"71","author":"Park","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2009.08.059_bib122","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1128\/IAI.01893-06","article-title":"Trivalent vaccine against botulinum toxin serotypes A, B, and E that can be administered by the mucosal route","volume":"75","author":"Ravichandran","year":"2007","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2009.08.059_bib123","series-title":"Botulinum toxin: therapeutic clinical practice & science","first-page":"374","article-title":"Botulism vaccines and the immune response","author":"Smith","year":"2009"},{"key":"10.1016\/j.vaccine.2009.08.059_bib124","series-title":"Treatment from toxins. The therapeutic potential of Clostridial neurotoxins","first-page":"75","article-title":"Vaccines to protect against neurotoxins","author":"Smith","year":"2006"},{"key":"10.1016\/j.vaccine.2009.08.059_bib125","series-title":"Presented at the 45th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC)","first-page":"G-918","article-title":"Initial evaluation of a recombinant Clostridium botulinum A\/B vaccine (rBV A\/B) in healthy volunteers","author":"Mckee","year":"2005"},{"key":"10.1016\/j.vaccine.2009.08.059_bib126","series-title":"Botulism proceedings of a symposium","first-page":"147","article-title":"Antitoxins to C. botulinum","author":"Cooper","year":"1964"},{"key":"10.1016\/j.vaccine.2009.08.059_bib127","series-title":"Presented at the ninth annual conference on vaccine research","first-page":"S19","article-title":"Protection against botulinum neurotoxin exposure in guinea pigs passively immunized with immune globulin purified from human volunteers vaccinated with recombinant botulinum vaccine (rBV A\/B)","author":"Henderson","year":"2006"},{"key":"10.1016\/j.vaccine.2009.08.059_bib128","series-title":"Presented at the 42nd Annual Interagency Botulinum Research Coordinating Committee Meeting (IBRCC)","first-page":"P26","article-title":"Impact of adjuvant and immunogenicity of a recombinant botulinum vaccine A\/B in healthy adult volunteers","author":"Swiderski","year":"2005"},{"key":"10.1016\/j.vaccine.2009.08.059_bib129","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.febslet.2004.06.094","article-title":"Interaction between the two subdomains of the C-terminal part of the botulinum neurotoxin A is essential for the generation of protective antibodies","volume":"572","author":"Tavallaie","year":"2004","journal-title":"FEBS Lett"},{"key":"10.1016\/j.vaccine.2009.08.059_bib130","doi-asserted-by":"crossref","first-page":"4586","DOI":"10.1128\/IAI.65.11.4586-4591.1997","article-title":"Induction of an immune response by an oral administration of recombinant botulinum toxin","volume":"65","author":"Kiyatkin","year":"1997","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2009.08.059_bib131","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S0041-0101(03)00042-4","article-title":"Expression, purification, and efficacy of type A botulinum neurotoxin catalytic domain fused to two translocation domain variants","volume":"41","author":"Jensen","year":"2003","journal-title":"Toxicon"},{"key":"10.1016\/j.vaccine.2009.08.059_bib132","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.pep.2005.09.024","article-title":"Expression, purification, and characterization of Clostridium botulinum type B light chain","volume":"46","author":"Gilsdorf","year":"2006","journal-title":"Protein Expr Purif"},{"key":"10.1016\/j.vaccine.2009.08.059_bib133","doi-asserted-by":"crossref","first-page":"4490","DOI":"10.1016\/j.vaccine.2009.05.030","article-title":"Production of catalytically inactive BoNT\/A1 holoprotein and comparison with BoNT\/A1 subunit vaccines against toxin subtypes A1, A2, and A3","volume":"27","author":"Webb","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.08.059_bib134","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1016\/j.vaccine.2009.02.051","article-title":"Localization of the sites and characterization of the mechanism by which anti-light chain antibodies neutralize the actions of the botulinum holotoxin","volume":"27","author":"Takahashi","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.08.059_bib135","series-title":"Scientific and therapeutic aspects of botulinum toxin","first-page":"427","article-title":"Vaccines for preventing botulism","author":"Smith","year":"2002"},{"key":"10.1016\/j.vaccine.2009.08.059_bib136","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S1046-5928(02)00002-5","article-title":"Expression and purification of catalytically active, non-toxic endopeptidase derivatives of Clostridium botulinum toxin type A","volume":"25","author":"Chaddock","year":"2002","journal-title":"Protein Expr Purif"},{"key":"10.1016\/j.vaccine.2009.08.059_bib137","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1128\/IAI.01252-08","article-title":"Bivalent recombinant vaccine for botulinum neurotoxin types A and B based on a polypeptide comprising their effector and translocation domains that is protective against the predominant A and B subtypes","volume":"77","author":"Shone","year":"2009","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2009.08.059_bib138","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1128\/IAI.00843-07","article-title":"Recombinant holotoxoid vaccine against botulism","volume":"76","author":"Pier","year":"2008","journal-title":"Infect Immun"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09012134?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09012134?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,27]],"date-time":"2023-05-27T06:22:27Z","timestamp":1685168547000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X09012134"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":138,"alternative-id":["S0264410X09012134"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2009.08.059","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,11]]}}}